oncolytic MSV (Themis Bioscience)

N/A

Report date: 2025/03/20 10:06:21

Base Information

Drug Nameoncolytic MSV (Themis Bioscience)
Drug Alias Nameoncolytic measles virus (Themis Bioscience)
ClassificationBiologics
Mechanisms of ActionMembrane cofactor protein modulatorsCytokines modulators
TargetsCytokinesMembrane cofactor protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMax Planck Innovation
China Registration ClassN/A

Develop Information

Active CompaniesThemis Bioscience Gmbh
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A